Antivirals
|
|
Your reliable supplier of generic medications.
|
|
|
I recently placed an order with your company for some viagra and was very pleased however I accidently deleted your website for ordering could you please re-send details?
Our billing is certified by:
- What’s best at beating swine flu, soap or gel?
Commuters obsessively scrub their hands with gel.
- Swine flu drug treatment will replace containment strategy
More than 150 people have been diagnosed with swine flu over the past 24 hours as the rate of infection accelerates, pushing the total number of UK cases above 1,000.
- Is the flu jab a waste of time?
On balance, probably not.
- Global flu pandemic would probably kill 62m, study says
Around 62 million people in the world are likely to die if there is a flu pandemic and more than 70,000 of those deaths will be in the UK, according to a statistical analysis published today.
- Vaccine against lethal strain of avian flu ready for human testing
A British drug company is seeking permission to conduct the first human trials of an experimental vaccine against the avian flu virus.
- The Global Antivirals Market Expected To Reach $30 Billion By 2017 - OfficialWire (press release)
The Global Antivirals Market Expected To Reach $30 Billion By 2017OfficialWire (press release)by Press Office In 2010, the global antivirals market was estimated to be worth $22.
- Another deadly pandemic a matter of when, not if - Brisbane Times
Another deadly pandemic a matter of when, not ifBrisbane TimesThe drugs that would help are the antivirals, such as Relenza and Tamiflu.
- Gastroenterology special issue focuses on new directions of viral hepatitis ... - Phys.Org (press release)
Gastroenterology special issue focuses on new directions of viral hepatitis .
- Theraputic Specialist - HIV - Pharma Times
Theraputic Specialist - HIVPharma TimesPrimary areas of focus include antivirals such as HIV/AIDS and chronic hepatitis, cardiovascular conditions such as pulmonary arterial hypertension and respiratory diseases including influenza and cystic fibrosis.
- New Antivirals Show Poor Safety in HCV With Cirrhosis - Medscape
New Antivirals Show Poor Safety in HCV With CirrhosisMedscapeMay 2, 2012 (Barcelona, Spain) — Two relatively new direct-acting antiviral drugs have poor safety profiles in patients with hepatitis C virus (HCV) and cirrhosis, including a high rate of serious adverse events leading to study discontinuation.
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
